The big pain point for employers is with their pharmaceutical contracts, especially given the explosive growth in new specialty drugs. (Photo: Shutterstock)
The more things change, the more they really do stay the same, to which any organization trying to effectively manage employee benefits in an unceasingly volatile environment will attest.
On one side, we continue to see health benefit costs on an unrelenting rise. More claims are trending from high to jumbo. Then, too are the near-miraculous, life-saving cures through gene therapy and specialty drugs with price tags that are out of reach for most who need them—and a worrisome burden for employers.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
